 Shawn St Peter
Concepts (944)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Laparoscopy | 102 | 2023 | 215 | 23.470 |
Why?
| | Appendicitis | 61 | 2023 | 118 | 19.510 |
Why?
| | Appendectomy | 51 | 2023 | 103 | 15.510 |
Why?
| | Humans | 424 | 2023 | 6599 | 13.680 |
Why?
| | Retrospective Studies | 236 | 2023 | 1251 | 12.840 |
Why?
| | Male | 256 | 2023 | 3197 | 11.220 |
Why?
| | Child | 266 | 2023 | 3146 | 10.860 |
Why?
| | Female | 256 | 2023 | 3436 | 10.640 |
Why?
| | Funnel Chest | 25 | 2022 | 55 | 9.900 |
Why?
| | Postoperative Complications | 66 | 2023 | 177 | 9.210 |
Why?
| | Treatment Outcome | 116 | 2023 | 624 | 7.910 |
Why?
| | Child, Preschool | 134 | 2022 | 1459 | 7.580 |
Why?
| | Adolescent | 149 | 2023 | 2087 | 7.190 |
Why?
| | Pain, Postoperative | 20 | 2022 | 39 | 7.160 |
Why?
| | Gastroesophageal Reflux | 19 | 2021 | 41 | 6.880 |
Why?
| | Fundoplication | 22 | 2021 | 36 | 6.830 |
Why?
| | Infant | 130 | 2023 | 1396 | 6.780 |
Why?
| | Wounds, Nonpenetrating | 30 | 2023 | 60 | 6.750 |
Why?
| | Prospective Studies | 78 | 2022 | 508 | 6.320 |
Why?
| | Abdominal Abscess | 15 | 2021 | 26 | 6.020 |
Why?
| | Anti-Bacterial Agents | 27 | 2021 | 238 | 5.730 |
Why?
| | Surgical Wound Infection | 21 | 2021 | 43 | 5.400 |
Why?
| | Tomography, X-Ray Computed | 41 | 2022 | 116 | 5.270 |
Why?
| | Analgesia, Patient-Controlled | 12 | 2019 | 18 | 4.990 |
Why?
| | Infant, Newborn | 93 | 2022 | 790 | 4.780 |
Why?
| | Length of Stay | 54 | 2023 | 227 | 4.540 |
Why?
| | Follow-Up Studies | 55 | 2021 | 315 | 4.380 |
Why?
| | Postoperative Care | 13 | 2020 | 28 | 3.970 |
Why?
| | Thoracoscopy | 17 | 2021 | 27 | 3.930 |
Why?
| | Foreign Bodies | 9 | 2021 | 22 | 3.850 |
Why?
| | Liver | 20 | 2023 | 119 | 3.700 |
Why?
| | Spleen | 16 | 2023 | 29 | 3.670 |
Why?
| | Cholecystectomy, Laparoscopic | 11 | 2021 | 27 | 3.440 |
Why?
| | Drainage | 16 | 2021 | 34 | 3.430 |
Why?
| | Minimally Invasive Surgical Procedures | 19 | 2022 | 38 | 3.270 |
Why?
| | Pyloric Stenosis, Hypertrophic | 9 | 2023 | 23 | 3.210 |
Why?
| | Esophagus | 12 | 2020 | 28 | 3.150 |
Why?
| | Pneumothorax | 12 | 2023 | 33 | 3.060 |
Why?
| | Empyema, Pleural | 6 | 2021 | 10 | 3.050 |
Why?
| | Gastrostomy | 13 | 2022 | 62 | 3.040 |
Why?
| | Gastroschisis | 11 | 2022 | 21 | 3.030 |
Why?
| | Enteral Nutrition | 14 | 2023 | 62 | 3.020 |
Why?
| | Pediatrics | 19 | 2020 | 170 | 2.940 |
Why?
| | Hernia, Inguinal | 13 | 2021 | 31 | 2.920 |
Why?
| | Randomized Controlled Trials as Topic | 12 | 2020 | 62 | 2.900 |
Why?
| | Esophageal Atresia | 14 | 2022 | 32 | 2.830 |
Why?
| | Hernias, Diaphragmatic, Congenital | 10 | 2016 | 20 | 2.830 |
Why?
| | Tracheoesophageal Fistula | 11 | 2022 | 26 | 2.690 |
Why?
| | Practice Patterns, Physicians' | 12 | 2021 | 82 | 2.570 |
Why?
| | Hospitals, Pediatric | 18 | 2021 | 178 | 2.570 |
Why?
| | Abdominal Injuries | 14 | 2023 | 27 | 2.550 |
Why?
| | Digestive System Surgical Procedures | 12 | 2019 | 38 | 2.480 |
Why?
| | Wounds and Injuries | 6 | 2022 | 35 | 2.390 |
Why?
| | Intussusception | 7 | 2020 | 12 | 2.350 |
Why?
| | Analgesia, Epidural | 4 | 2019 | 10 | 2.330 |
Why?
| | Time Factors | 30 | 2019 | 241 | 2.250 |
Why?
| | Ceftriaxone | 7 | 2015 | 13 | 2.250 |
Why?
| | Clinical Protocols | 10 | 2018 | 35 | 2.240 |
Why?
| | Pyloric Stenosis | 6 | 2016 | 12 | 2.220 |
Why?
| | Cryosurgery | 3 | 2022 | 13 | 2.220 |
Why?
| | Hirschsprung Disease | 8 | 2022 | 53 | 2.210 |
Why?
| | Tissue Plasminogen Activator | 4 | 2020 | 5 | 2.060 |
Why?
| | Herniorrhaphy | 10 | 2021 | 25 | 2.000 |
Why?
| | Sutures | 5 | 2021 | 11 | 1.980 |
Why?
| | Anesthesia, Epidural | 4 | 2015 | 4 | 1.910 |
Why?
| | Surgical Mesh | 6 | 2012 | 8 | 1.820 |
Why?
| | United States | 36 | 2023 | 646 | 1.790 |
Why?
| | Metronidazole | 6 | 2015 | 14 | 1.750 |
Why?
| | Reoperation | 19 | 2022 | 57 | 1.710 |
Why?
| | Crohn Disease | 4 | 2014 | 21 | 1.710 |
Why?
| | Colitis, Ulcerative | 3 | 2023 | 9 | 1.700 |
Why?
| | Laparotomy | 12 | 2021 | 21 | 1.700 |
Why?
| | Suture Techniques | 6 | 2020 | 10 | 1.680 |
Why?
| | Algorithms | 12 | 2023 | 103 | 1.680 |
Why?
| | Catheterization, Central Venous | 6 | 2016 | 18 | 1.660 |
Why?
| | Abdominal Pain | 5 | 2019 | 64 | 1.630 |
Why?
| | Intestinal Obstruction | 8 | 2019 | 19 | 1.600 |
Why?
| | Hernia, Hiatal | 5 | 2015 | 7 | 1.590 |
Why?
| | Suction | 5 | 2015 | 8 | 1.570 |
Why?
| | General Surgery | 8 | 2016 | 18 | 1.550 |
Why?
| | Thoracic Surgery, Video-Assisted | 7 | 2023 | 18 | 1.540 |
Why?
| | Hernia, Umbilical | 7 | 2022 | 15 | 1.530 |
Why?
| | Trauma Centers | 17 | 2023 | 41 | 1.520 |
Why?
| | Pylorus | 7 | 2015 | 12 | 1.510 |
Why?
| | Cicatrix | 3 | 2016 | 5 | 1.510 |
Why?
| | Operative Time | 13 | 2022 | 31 | 1.500 |
Why?
| | Hernia, Diaphragmatic | 8 | 2012 | 14 | 1.490 |
Why?
| | Esophagoscopy | 5 | 2020 | 11 | 1.470 |
Why?
| | Cryptorchidism | 4 | 2022 | 8 | 1.450 |
Why?
| | Umbilicus | 5 | 2018 | 9 | 1.440 |
Why?
| | Peritoneal Lavage | 3 | 2015 | 6 | 1.430 |
Why?
| | Costal Cartilage | 2 | 2021 | 4 | 1.380 |
Why?
| | Recurrence | 20 | 2023 | 115 | 1.380 |
Why?
| | Severity of Illness Index | 7 | 2018 | 142 | 1.370 |
Why?
| | Fibrinolytic Agents | 4 | 2015 | 5 | 1.370 |
Why?
| | Urinary Retention | 4 | 2018 | 5 | 1.340 |
Why?
| | Enterocolitis, Necrotizing | 11 | 2021 | 67 | 1.320 |
Why?
| | Ileum | 3 | 2014 | 15 | 1.300 |
Why?
| | Specialties, Surgical | 6 | 2016 | 13 | 1.290 |
Why?
| | Circumcision, Male | 2 | 2018 | 3 | 1.290 |
Why?
| | Unnecessary Procedures | 4 | 2023 | 13 | 1.290 |
Why?
| | Kidney | 5 | 2013 | 89 | 1.280 |
Why?
| | Evidence-Based Medicine | 8 | 2014 | 43 | 1.280 |
Why?
| | Intestinal Volvulus | 5 | 2019 | 12 | 1.270 |
Why?
| | Risk Factors | 23 | 2022 | 460 | 1.270 |
Why?
| | Abscess | 5 | 2014 | 10 | 1.260 |
Why?
| | Gallbladder Diseases | 4 | 2016 | 13 | 1.260 |
Why?
| | Adult | 25 | 2022 | 1233 | 1.250 |
Why?
| | Ribs | 3 | 2021 | 6 | 1.230 |
Why?
| | Radiography, Thoracic | 5 | 2017 | 12 | 1.210 |
Why?
| | Enterocolitis | 3 | 2022 | 34 | 1.200 |
Why?
| | Quality Improvement | 6 | 2018 | 60 | 1.170 |
Why?
| | Obesity | 4 | 2022 | 124 | 1.170 |
Why?
| | Bed Rest | 5 | 2013 | 10 | 1.160 |
Why?
| | Intestinal Perforation | 7 | 2021 | 11 | 1.160 |
Why?
| | Patient Discharge | 8 | 2023 | 58 | 1.160 |
Why?
| | Preoperative Care | 12 | 2023 | 25 | 1.150 |
Why?
| | Ileal Diseases | 3 | 2018 | 7 | 1.150 |
Why?
| | Databases, Factual | 8 | 2021 | 105 | 1.150 |
Why?
| | Thrombolytic Therapy | 2 | 2021 | 5 | 1.130 |
Why?
| | Cholelithiasis | 3 | 2015 | 7 | 1.120 |
Why?
| | Fluoroscopy | 7 | 2020 | 19 | 1.110 |
Why?
| | Radiography | 8 | 2018 | 38 | 1.110 |
Why?
| | Appendix | 4 | 2018 | 11 | 1.100 |
Why?
| | Esophageal Achalasia | 2 | 2016 | 3 | 1.100 |
Why?
| | Pain Measurement | 7 | 2019 | 44 | 1.090 |
Why?
| | Incidence | 27 | 2020 | 125 | 1.080 |
Why?
| | Surveys and Questionnaires | 13 | 2022 | 290 | 1.050 |
Why?
| | Biliary Dyskinesia | 4 | 2019 | 8 | 1.050 |
Why?
| | Blood Transfusion | 6 | 2017 | 13 | 1.050 |
Why?
| | Colitis | 2 | 2023 | 12 | 1.020 |
Why?
| | Electric Power Supplies | 2 | 2021 | 4 | 1.010 |
Why?
| | Thoracotomy | 4 | 2023 | 17 | 0.990 |
Why?
| | Chest Tubes | 8 | 2023 | 24 | 0.980 |
Why?
| | Esophageal Perforation | 2 | 2017 | 4 | 0.980 |
Why?
| | Combined Modality Therapy | 11 | 2018 | 51 | 0.980 |
Why?
| | Orthopedic Procedures | 5 | 2018 | 16 | 0.970 |
Why?
| | Biomedical Research | 4 | 2018 | 20 | 0.960 |
Why?
| | Urinary Catheterization | 4 | 2018 | 4 | 0.960 |
Why?
| | Ambulatory Surgical Procedures | 5 | 2018 | 14 | 0.960 |
Why?
| | Thoracic Surgical Procedures | 5 | 2011 | 10 | 0.960 |
Why?
| | Burns | 5 | 2023 | 16 | 0.950 |
Why?
| | Histamine H2 Antagonists | 3 | 2017 | 7 | 0.930 |
Why?
| | Age Factors | 12 | 2021 | 203 | 0.920 |
Why?
| | Injury Severity Score | 15 | 2023 | 58 | 0.910 |
Why?
| | Catheterization | 4 | 2016 | 27 | 0.910 |
Why?
| | Stomach | 3 | 2018 | 11 | 0.900 |
Why?
| | Enema | 6 | 2020 | 13 | 0.900 |
Why?
| | Cecum | 2 | 2014 | 4 | 0.900 |
Why?
| | Risk Assessment | 13 | 2023 | 130 | 0.900 |
Why?
| | Patient Satisfaction | 10 | 2019 | 41 | 0.890 |
Why?
| | Lung Diseases | 2 | 2022 | 23 | 0.880 |
Why?
| | Young Adult | 14 | 2023 | 652 | 0.880 |
Why?
| | Child Abuse | 3 | 2022 | 45 | 0.880 |
Why?
| | Clinical Trials as Topic | 4 | 2018 | 44 | 0.880 |
Why?
| | Intercostal Nerves | 2 | 2022 | 7 | 0.880 |
Why?
| | Intestine, Small | 6 | 2014 | 14 | 0.870 |
Why?
| | Antibiotic Prophylaxis | 8 | 2021 | 28 | 0.860 |
Why?
| | Clinical Decision-Making | 3 | 2021 | 20 | 0.860 |
Why?
| | Esophagoplasty | 3 | 2020 | 4 | 0.860 |
Why?
| | Splenectomy | 5 | 2017 | 7 | 0.850 |
Why?
| | Pancreas | 4 | 2017 | 9 | 0.840 |
Why?
| | Intubation, Gastrointestinal | 5 | 2018 | 18 | 0.830 |
Why?
| | Perioperative Care | 2 | 2018 | 10 | 0.820 |
Why?
| | Equipment Contamination | 2 | 2021 | 6 | 0.820 |
Why?
| | Pancreatitis | 4 | 2022 | 8 | 0.810 |
Why?
| | Ovarian Neoplasms | 3 | 2023 | 132 | 0.810 |
Why?
| | Protective Clothing | 1 | 2021 | 2 | 0.790 |
Why?
| | Fomites | 1 | 2021 | 2 | 0.790 |
Why?
| | Electrical Equipment and Supplies | 1 | 2021 | 2 | 0.790 |
Why?
| | Surgical Attire | 1 | 2021 | 2 | 0.790 |
Why?
| | Prognosis | 15 | 2019 | 209 | 0.790 |
Why?
| | Critical Pathways | 3 | 2018 | 9 | 0.790 |
Why?
| | Birth Weight | 7 | 2018 | 27 | 0.790 |
Why?
| | Numismatics | 1 | 2020 | 3 | 0.780 |
Why?
| | Pneumoperitoneum, Artificial | 2 | 2011 | 5 | 0.780 |
Why?
| | Respiratory Insufficiency | 3 | 2019 | 12 | 0.770 |
Why?
| | Intestinal Atresia | 4 | 2023 | 18 | 0.760 |
Why?
| | Heart Defects, Congenital | 4 | 2018 | 81 | 0.760 |
Why?
| | Cohort Studies | 14 | 2022 | 264 | 0.750 |
Why?
| | Intraoperative Care | 3 | 2018 | 6 | 0.750 |
Why?
| | Acute Disease | 8 | 2023 | 71 | 0.750 |
Why?
| | Ultrasonography | 10 | 2019 | 42 | 0.740 |
Why?
| | Biocompatible Materials | 2 | 2012 | 2 | 0.740 |
Why?
| | Diagnostic Imaging | 2 | 2017 | 14 | 0.740 |
Why?
| | Guideline Adherence | 1 | 2020 | 33 | 0.730 |
Why?
| | Research Design | 3 | 2020 | 64 | 0.730 |
Why?
| | Gallstones | 3 | 2022 | 4 | 0.730 |
Why?
| | Orchiopexy | 3 | 2022 | 6 | 0.730 |
Why?
| | Testis | 3 | 2022 | 7 | 0.730 |
Why?
| | Surgical Procedures, Operative | 5 | 2020 | 12 | 0.720 |
Why?
| | Liver Transplantation | 4 | 2004 | 43 | 0.710 |
Why?
| | Sensitivity and Specificity | 10 | 2018 | 145 | 0.710 |
Why?
| | Tissue Adhesions | 2 | 2017 | 6 | 0.710 |
Why?
| | Medical Errors | 1 | 2019 | 7 | 0.700 |
Why?
| | Pericardium | 2 | 2011 | 5 | 0.700 |
Why?
| | Thoracostomy | 4 | 2021 | 8 | 0.690 |
Why?
| | Internship and Residency | 4 | 2023 | 31 | 0.680 |
Why?
| | Drug Therapy, Combination | 7 | 2018 | 38 | 0.680 |
Why?
| | Analgesics, Opioid | 6 | 2022 | 44 | 0.680 |
Why?
| | Sodium Chloride | 2 | 2016 | 3 | 0.670 |
Why?
| | Data Interpretation, Statistical | 1 | 2018 | 20 | 0.670 |
Why?
| | Fluid Therapy | 3 | 2023 | 19 | 0.670 |
Why?
| | Hypertension, Pulmonary | 2 | 2017 | 8 | 0.670 |
Why?
| | Pleural Effusion | 3 | 2016 | 5 | 0.670 |
Why?
| | Phimosis | 1 | 2018 | 1 | 0.660 |
Why?
| | Colonic Diseases | 3 | 2014 | 5 | 0.660 |
Why?
| | Neuromuscular Diseases | 1 | 2018 | 7 | 0.660 |
Why?
| | Malnutrition | 1 | 2018 | 8 | 0.650 |
Why?
| | Tissue Adhesives | 2 | 2017 | 3 | 0.650 |
Why?
| | Gestational Age | 12 | 2019 | 61 | 0.650 |
Why?
| | Bronchoscopy | 5 | 2016 | 7 | 0.640 |
Why?
| | Drug Administration Schedule | 7 | 2018 | 40 | 0.640 |
Why?
| | Extracorporeal Membrane Oxygenation | 3 | 2016 | 17 | 0.640 |
Why?
| | Sample Size | 1 | 2017 | 3 | 0.640 |
Why?
| | Lung Neoplasms | 4 | 2022 | 22 | 0.630 |
Why?
| | Abnormalities, Multiple | 6 | 2018 | 36 | 0.630 |
Why?
| | Referral and Consultation | 1 | 2018 | 33 | 0.630 |
Why?
| | Colectomy | 2 | 2023 | 13 | 0.630 |
Why?
| | Cyanoacrylates | 1 | 2017 | 2 | 0.630 |
Why?
| | Administration, Oral | 9 | 2018 | 59 | 0.630 |
Why?
| | Endoscopy, Gastrointestinal | 5 | 2019 | 17 | 0.620 |
Why?
| | Diagnosis, Differential | 10 | 2021 | 74 | 0.620 |
Why?
| | Anastomosis, Surgical | 7 | 2023 | 22 | 0.620 |
Why?
| | Ranitidine | 2 | 2015 | 5 | 0.620 |
Why?
| | Esophageal pH Monitoring | 3 | 2012 | 4 | 0.610 |
Why?
| | Disease Management | 4 | 2021 | 36 | 0.600 |
Why?
| | Therapeutic Irrigation | 4 | 2022 | 8 | 0.600 |
Why?
| | Dissection | 2 | 2014 | 3 | 0.600 |
Why?
| | Pulmonary Emphysema | 2 | 2019 | 2 | 0.590 |
Why?
| | Device Removal | 4 | 2014 | 13 | 0.590 |
Why?
| | Quality of Life | 3 | 2021 | 131 | 0.590 |
Why?
| | Cartilage Diseases | 1 | 2016 | 3 | 0.590 |
Why?
| | Joint Diseases | 1 | 2016 | 4 | 0.590 |
Why?
| | Health Resources | 2 | 2014 | 17 | 0.590 |
Why?
| | Fever | 2 | 2014 | 26 | 0.580 |
Why?
| | Pilonidal Sinus | 2 | 2019 | 4 | 0.580 |
Why?
| | Proctocolectomy, Restorative | 2 | 2020 | 3 | 0.570 |
Why?
| | Patient Readmission | 7 | 2020 | 66 | 0.570 |
Why?
| | Predictive Value of Tests | 8 | 2023 | 99 | 0.570 |
Why?
| | Refusal to Participate | 1 | 2016 | 1 | 0.570 |
Why?
| | Radiography, Interventional | 1 | 2016 | 1 | 0.570 |
Why?
| | High-Frequency Ventilation | 2 | 2016 | 4 | 0.560 |
Why?
| | Emergency Service, Hospital | 6 | 2020 | 129 | 0.560 |
Why?
| | Rectum | 5 | 2019 | 25 | 0.560 |
Why?
| | Pancreatectomy | 2 | 2013 | 5 | 0.560 |
Why?
| | Organ Preservation | 4 | 2003 | 5 | 0.560 |
Why?
| | Nervous System Diseases | 2 | 2014 | 13 | 0.550 |
Why?
| | Hospital Costs | 3 | 2016 | 27 | 0.550 |
Why?
| | Body Mass Index | 7 | 2016 | 155 | 0.550 |
Why?
| | Duodenal Obstruction | 5 | 2023 | 15 | 0.550 |
Why?
| | Overweight | 3 | 2014 | 48 | 0.540 |
Why?
| | Patient Selection | 4 | 2021 | 40 | 0.540 |
Why?
| | Meckel Diverticulum | 3 | 2018 | 7 | 0.540 |
Why?
| | Cost-Benefit Analysis | 6 | 2016 | 36 | 0.530 |
Why?
| | Wounds, Gunshot | 4 | 2022 | 12 | 0.530 |
Why?
| | Esophageal Sphincter, Lower | 1 | 2015 | 1 | 0.530 |
Why?
| | Dilatation | 1 | 2015 | 2 | 0.530 |
Why?
| | Gastric Fistula | 1 | 2015 | 3 | 0.530 |
Why?
| | Cutaneous Fistula | 1 | 2015 | 3 | 0.530 |
Why?
| | Diagnostic Self Evaluation | 2 | 2021 | 2 | 0.520 |
Why?
| | Anti-Infective Agents | 1 | 2015 | 21 | 0.520 |
Why?
| | Proton Pump Inhibitors | 1 | 2015 | 13 | 0.520 |
Why?
| | Ileostomy | 2 | 2011 | 3 | 0.510 |
Why?
| | Hospitalization | 8 | 2023 | 192 | 0.500 |
Why?
| | Apnea | 2 | 2012 | 5 | 0.500 |
Why?
| | Treatment Failure | 7 | 2019 | 17 | 0.500 |
Why?
| | Neutropenia | 2 | 2011 | 13 | 0.500 |
Why?
| | Vascular Access Devices | 1 | 2014 | 1 | 0.490 |
Why?
| | Needles | 1 | 2014 | 3 | 0.490 |
Why?
| | Equipment Failure | 1 | 2014 | 9 | 0.490 |
Why?
| | Prosthesis Implantation | 2 | 2010 | 5 | 0.480 |
Why?
| | Respiratory Aspiration | 1 | 2013 | 1 | 0.480 |
Why?
| | Postoperative Period | 7 | 2018 | 17 | 0.470 |
Why?
| | Pain Threshold | 1 | 2013 | 3 | 0.470 |
Why?
| | Personal Satisfaction | 3 | 2023 | 9 | 0.470 |
Why?
| | Diaphragm | 2 | 2010 | 7 | 0.470 |
Why?
| | Debridement | 2 | 2012 | 5 | 0.470 |
Why?
| | Postoperative Nausea and Vomiting | 2 | 2013 | 6 | 0.460 |
Why?
| | Contrast Media | 3 | 2014 | 24 | 0.460 |
Why?
| | Venous Thrombosis | 1 | 2013 | 2 | 0.460 |
Why?
| | Elective Surgical Procedures | 4 | 2018 | 14 | 0.450 |
Why?
| | Lung | 5 | 2022 | 65 | 0.450 |
Why?
| | Abdominal Wall | 3 | 2020 | 5 | 0.450 |
Why?
| | Tietze's Syndrome | 1 | 2012 | 1 | 0.450 |
Why?
| | Therapeutic Equipoise | 1 | 2012 | 1 | 0.450 |
Why?
| | Cartilage | 1 | 2012 | 2 | 0.450 |
Why?
| | Biopsy | 6 | 2019 | 56 | 0.450 |
Why?
| | Comorbidity | 6 | 2017 | 61 | 0.440 |
Why?
| | Genital Diseases, Male | 1 | 2012 | 1 | 0.440 |
Why?
| | Decision Making | 1 | 2013 | 34 | 0.440 |
Why?
| | Hemangioma | 1 | 2012 | 1 | 0.440 |
Why?
| | Splenic Neoplasms | 1 | 2012 | 1 | 0.440 |
Why?
| | Infant, Premature, Diseases | 4 | 2021 | 23 | 0.440 |
Why?
| | Nod2 Signaling Adaptor Protein | 1 | 2012 | 3 | 0.440 |
Why?
| | Silver Sulfadiazine | 1 | 2012 | 5 | 0.440 |
Why?
| | Collagenases | 1 | 2012 | 5 | 0.440 |
Why?
| | Ovarian Cysts | 1 | 2012 | 2 | 0.430 |
Why?
| | Societies, Medical | 5 | 2017 | 43 | 0.430 |
Why?
| | Reproducibility of Results | 9 | 2022 | 197 | 0.430 |
Why?
| | Firearms | 2 | 2022 | 8 | 0.430 |
Why?
| | Cystadenoma, Mucinous | 1 | 2012 | 1 | 0.430 |
Why?
| | Practice Guidelines as Topic | 6 | 2021 | 96 | 0.430 |
Why?
| | Middle Aged | 7 | 2016 | 648 | 0.430 |
Why?
| | Heart Injuries | 1 | 2011 | 4 | 0.420 |
Why?
| | Insufflation | 1 | 2011 | 3 | 0.420 |
Why?
| | Cystic Adenomatoid Malformation of Lung, Congenital | 1 | 2011 | 1 | 0.420 |
Why?
| | Single-Blind Method | 4 | 2018 | 12 | 0.420 |
Why?
| | Monitoring, Physiologic | 1 | 2012 | 24 | 0.420 |
Why?
| | Anticoagulants | 2 | 2013 | 17 | 0.410 |
Why?
| | Adrenalectomy | 1 | 2011 | 1 | 0.410 |
Why?
| | Insurance Coverage | 2 | 2022 | 19 | 0.410 |
Why?
| | Thorax | 1 | 2011 | 4 | 0.400 |
Why?
| | Sports Equipment | 1 | 2011 | 2 | 0.400 |
Why?
| | Accidents, Home | 1 | 2011 | 6 | 0.400 |
Why?
| | Health Care Surveys | 5 | 2018 | 32 | 0.400 |
Why?
| | Pulmonary Blastoma | 3 | 2022 | 5 | 0.390 |
Why?
| | Iatrogenic Disease | 2 | 2010 | 7 | 0.390 |
Why?
| | Ossification, Heterotopic | 1 | 2010 | 2 | 0.390 |
Why?
| | Thymoma | 1 | 2010 | 2 | 0.390 |
Why?
| | Thymus Neoplasms | 1 | 2010 | 3 | 0.390 |
Why?
| | Abdomen | 3 | 2022 | 13 | 0.390 |
Why?
| | Jejunal Diseases | 1 | 2010 | 3 | 0.390 |
Why?
| | Periodicity | 1 | 2010 | 3 | 0.380 |
Why?
| | Duodenal Diseases | 1 | 2010 | 4 | 0.380 |
Why?
| | Decompression, Surgical | 1 | 2010 | 3 | 0.380 |
Why?
| | Nutritional Support | 1 | 2010 | 5 | 0.380 |
Why?
| | Xiphoid Bone | 1 | 2010 | 5 | 0.380 |
Why?
| | Fecal Incontinence | 3 | 2020 | 19 | 0.380 |
Why?
| | Adenomatous Polyposis Coli | 1 | 2010 | 24 | 0.380 |
Why?
| | Laparoscopes | 1 | 2010 | 1 | 0.370 |
Why?
| | Cholecystectomy | 4 | 2022 | 8 | 0.370 |
Why?
| | Histamine H1 Antagonists | 1 | 2010 | 2 | 0.370 |
Why?
| | Digestive System Abnormalities | 2 | 2009 | 7 | 0.370 |
Why?
| | Cholangiopancreatography, Endoscopic Retrograde | 4 | 2018 | 5 | 0.370 |
Why?
| | Radiographic Image Interpretation, Computer-Assisted | 1 | 2010 | 4 | 0.370 |
Why?
| | Bezoars | 1 | 2009 | 2 | 0.370 |
Why?
| | Empyema | 2 | 2009 | 3 | 0.370 |
Why?
| | Ventriculoperitoneal Shunt | 1 | 2009 | 5 | 0.360 |
Why?
| | Infant, Premature | 7 | 2021 | 81 | 0.360 |
Why?
| | Intestinal Mucosa | 3 | 2019 | 34 | 0.360 |
Why?
| | Case-Control Studies | 6 | 2022 | 202 | 0.360 |
Why?
| | Ileocecal Valve | 1 | 2009 | 2 | 0.360 |
Why?
| | Wounds, Penetrating | 2 | 2023 | 5 | 0.360 |
Why?
| | Parents | 3 | 2016 | 149 | 0.360 |
Why?
| | Colon | 3 | 2015 | 12 | 0.350 |
Why?
| | Esophageal Stenosis | 3 | 2022 | 5 | 0.350 |
Why?
| | Thrombin | 1 | 2009 | 1 | 0.350 |
Why?
| | Wounds, Stab | 1 | 2009 | 1 | 0.350 |
Why?
| | Tibial Arteries | 1 | 2009 | 1 | 0.350 |
Why?
| | Ultrasonography, Interventional | 1 | 2009 | 3 | 0.350 |
Why?
| | Aneurysm, False | 1 | 2009 | 2 | 0.350 |
Why?
| | Hemostatics | 1 | 2009 | 3 | 0.350 |
Why?
| | Longitudinal Studies | 4 | 2021 | 123 | 0.350 |
Why?
| | Cholecystitis | 2 | 2008 | 6 | 0.340 |
Why?
| | Survival Rate | 6 | 2021 | 84 | 0.340 |
Why?
| | Alkalosis | 1 | 2008 | 1 | 0.340 |
Why?
| | Hypokalemia | 1 | 2008 | 1 | 0.340 |
Why?
| | Regression Analysis | 4 | 2019 | 56 | 0.340 |
Why?
| | Braces | 2 | 2019 | 10 | 0.330 |
Why?
| | Hemorrhage | 2 | 2019 | 18 | 0.330 |
Why?
| | Pectus Carinatum | 2 | 2019 | 10 | 0.330 |
Why?
| | Anesthetics | 2 | 2021 | 4 | 0.330 |
Why?
| | Missouri | 5 | 2018 | 78 | 0.330 |
Why?
| | Workload | 1 | 2008 | 9 | 0.330 |
Why?
| | Gentamicins | 1 | 2008 | 5 | 0.330 |
Why?
| | Medical Staff, Hospital | 1 | 2008 | 4 | 0.330 |
Why?
| | Aged | 5 | 2015 | 375 | 0.330 |
Why?
| | Trauma Severity Indices | 4 | 2013 | 15 | 0.330 |
Why?
| | Patient Care Team | 1 | 2008 | 19 | 0.330 |
Why?
| | Inflammatory Bowel Diseases | 2 | 2020 | 40 | 0.320 |
Why?
| | Anesthesia, Intravenous | 1 | 2008 | 1 | 0.320 |
Why?
| | Splenic Rupture | 1 | 2008 | 2 | 0.320 |
Why?
| | Milk, Human | 3 | 2019 | 21 | 0.320 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 2 | 2010 | 71 | 0.320 |
Why?
| | Gastrointestinal Hemorrhage | 1 | 2018 | 15 | 0.320 |
Why?
| | Internal Fixators | 1 | 2007 | 3 | 0.320 |
Why?
| | Electrolytes | 3 | 2021 | 13 | 0.310 |
Why?
| | Hospital Charges | 3 | 2016 | 11 | 0.310 |
Why?
| | Pandemics | 6 | 2023 | 78 | 0.310 |
Why?
| | Antithrombin III | 1 | 2007 | 2 | 0.310 |
Why?
| | Disseminated Intravascular Coagulation | 1 | 2007 | 2 | 0.310 |
Why?
| | Hernia | 2 | 2018 | 2 | 0.310 |
Why?
| | Pain | 4 | 2020 | 53 | 0.300 |
Why?
| | Pneumonectomy | 3 | 2021 | 4 | 0.300 |
Why?
| | Logistic Models | 4 | 2019 | 91 | 0.300 |
Why?
| | Airway Obstruction | 3 | 2013 | 13 | 0.300 |
Why?
| | Ovariectomy | 2 | 2023 | 3 | 0.300 |
Why?
| | Aortic Aneurysm, Abdominal | 1 | 2006 | 1 | 0.300 |
Why?
| | Gastrointestinal Diseases | 2 | 2017 | 45 | 0.300 |
Why?
| | Hypertension, Renovascular | 1 | 2006 | 3 | 0.300 |
Why?
| | Vascular Surgical Procedures | 1 | 2006 | 3 | 0.300 |
Why?
| | Blood Vessels | 1 | 2006 | 5 | 0.290 |
Why?
| | Eating | 3 | 2021 | 28 | 0.290 |
Why?
| | Shock, Septic | 2 | 2021 | 4 | 0.290 |
Why?
| | Precursor Cell Lymphoblastic Leukemia-Lymphoma | 3 | 2021 | 60 | 0.290 |
Why?
| | Radiation Dosage | 3 | 2014 | 5 | 0.290 |
Why?
| | Ostomy | 2 | 2018 | 4 | 0.280 |
Why?
| | Rectal Prolapse | 2 | 2020 | 9 | 0.280 |
Why?
| | Forecasting | 2 | 2020 | 20 | 0.280 |
Why?
| | Multiple Trauma | 3 | 2013 | 12 | 0.280 |
Why?
| | Superior Mesenteric Artery Syndrome | 2 | 2020 | 4 | 0.280 |
Why?
| | Infant, Newborn, Diseases | 3 | 2018 | 32 | 0.280 |
Why?
| | Delivery, Obstetric | 1 | 2005 | 3 | 0.280 |
Why?
| | Intention to Treat Analysis | 2 | 2018 | 8 | 0.270 |
Why?
| | Pleura | 1 | 2005 | 1 | 0.270 |
Why?
| | Thoracic Injuries | 2 | 2021 | 8 | 0.270 |
Why?
| | Spherocytosis, Hereditary | 2 | 2015 | 3 | 0.270 |
Why?
| | Feasibility Studies | 4 | 2021 | 66 | 0.270 |
Why?
| | Duodenum | 2 | 2020 | 18 | 0.270 |
Why?
| | Guidelines as Topic | 2 | 2018 | 11 | 0.270 |
Why?
| | Urinary Diversion | 1 | 2005 | 1 | 0.260 |
Why?
| | Anal Canal | 2 | 2022 | 23 | 0.260 |
Why?
| | Anemia, Sickle Cell | 2 | 2015 | 17 | 0.260 |
Why?
| | Hydrogen-Ion Concentration | 3 | 2011 | 20 | 0.260 |
Why?
| | Gastric Bypass | 1 | 2005 | 8 | 0.260 |
Why?
| | Morbidity | 2 | 2016 | 11 | 0.260 |
Why?
| | Pilot Projects | 3 | 2019 | 124 | 0.260 |
Why?
| | Surgical Stomas | 2 | 2018 | 3 | 0.260 |
Why?
| | Recovery of Function | 3 | 2019 | 15 | 0.260 |
Why?
| | Gastrointestinal Tract | 2 | 2018 | 7 | 0.260 |
Why?
| | Colorectal Surgery | 2 | 2014 | 6 | 0.250 |
Why?
| | Bile Ducts, Extrahepatic | 1 | 2004 | 1 | 0.250 |
Why?
| | Pain Management | 2 | 2015 | 25 | 0.250 |
Why?
| | Chest Pain | 2 | 2021 | 3 | 0.250 |
Why?
| | ROC Curve | 2 | 2016 | 18 | 0.250 |
Why?
| | Prevalence | 4 | 2018 | 145 | 0.250 |
Why?
| | Enterocolitis, Pseudomembranous | 1 | 2004 | 4 | 0.250 |
Why?
| | Evidence-Based Practice | 5 | 2023 | 16 | 0.250 |
Why?
| | Esthetics | 3 | 2013 | 7 | 0.250 |
Why?
| | Intraoperative Complications | 2 | 2015 | 4 | 0.240 |
Why?
| | Pregnancy | 5 | 2022 | 203 | 0.240 |
Why?
| | Chemoembolization, Therapeutic | 1 | 2003 | 1 | 0.240 |
Why?
| | Hemangioendothelioma, Epithelioid | 1 | 2003 | 1 | 0.240 |
Why?
| | Plastics | 2 | 2014 | 2 | 0.240 |
Why?
| | Vomiting | 3 | 2020 | 23 | 0.240 |
Why?
| | Pneumonia | 3 | 2017 | 30 | 0.240 |
Why?
| | Liver Neoplasms | 1 | 2003 | 15 | 0.240 |
Why?
| | Splenic Diseases | 2 | 2017 | 2 | 0.240 |
Why?
| | Skin Transplantation | 2 | 2014 | 7 | 0.240 |
Why?
| | Liver Circulation | 1 | 2003 | 2 | 0.230 |
Why?
| | Registries | 3 | 2019 | 85 | 0.230 |
Why?
| | Rupture, Spontaneous | 3 | 2016 | 7 | 0.230 |
Why?
| | Gastrointestinal Agents | 1 | 2023 | 4 | 0.230 |
Why?
| | Infliximab | 1 | 2023 | 7 | 0.230 |
Why?
| | Steroids | 1 | 2023 | 14 | 0.230 |
Why?
| | Age Distribution | 4 | 2013 | 31 | 0.230 |
Why?
| | Lethargy | 2 | 2013 | 2 | 0.230 |
Why?
| | Injections, Intravenous | 2 | 2015 | 13 | 0.230 |
Why?
| | Chlorides | 2 | 2016 | 4 | 0.230 |
Why?
| | Bicarbonates | 2 | 2016 | 8 | 0.230 |
Why?
| | Clinical Competence | 2 | 2015 | 32 | 0.230 |
Why?
| | Prenatal Diagnosis | 5 | 2021 | 13 | 0.230 |
Why?
| | Hypoplastic Left Heart Syndrome | 2 | 2014 | 21 | 0.220 |
Why?
| | Adenocarcinoma, Mucinous | 1 | 2022 | 6 | 0.220 |
Why?
| | Propensity Score | 2 | 2021 | 8 | 0.220 |
Why?
| | Respiratory System Abnormalities | 2 | 2019 | 3 | 0.220 |
Why?
| | Endoscopy | 2 | 2012 | 15 | 0.220 |
Why?
| | Equipment Design | 3 | 2014 | 13 | 0.220 |
Why?
| | Stomach Neoplasms | 1 | 2022 | 6 | 0.220 |
Why?
| | Anthropometry | 2 | 2012 | 16 | 0.220 |
Why?
| | Opioid-Related Disorders | 1 | 2022 | 15 | 0.210 |
Why?
| | Testicular Neoplasms | 1 | 2022 | 2 | 0.210 |
Why?
| | Surgeons | 3 | 2016 | 5 | 0.210 |
Why?
| | Craniocerebral Trauma | 2 | 2014 | 18 | 0.210 |
Why?
| | Masks | 1 | 2021 | 7 | 0.210 |
Why?
| | Community-Acquired Infections | 2 | 2011 | 9 | 0.210 |
Why?
| | Neurodevelopmental Disorders | 1 | 2021 | 19 | 0.210 |
Why?
| | Statistics, Nonparametric | 1 | 2021 | 19 | 0.200 |
Why?
| | Pleural Diseases | 3 | 2011 | 5 | 0.200 |
Why?
| | Phyllodes Tumor | 1 | 2021 | 1 | 0.200 |
Why?
| | Fibroadenoma | 1 | 2021 | 1 | 0.200 |
Why?
| | Mastectomy, Segmental | 1 | 2021 | 4 | 0.200 |
Why?
| | Hypothermia | 1 | 2021 | 2 | 0.200 |
Why?
| | Watchful Waiting | 1 | 2021 | 7 | 0.200 |
Why?
| | Sepsis | 2 | 2019 | 22 | 0.200 |
Why?
| | Anesthesia, General | 1 | 2021 | 1 | 0.200 |
Why?
| | Patient Compliance | 2 | 2019 | 70 | 0.200 |
Why?
| | Eosinophilia | 2 | 2019 | 20 | 0.200 |
Why?
| | Immunotherapy, Adoptive | 1 | 2021 | 6 | 0.200 |
Why?
| | Cholangiopancreatography, Magnetic Resonance | 2 | 2018 | 3 | 0.200 |
Why?
| | Animals | 4 | 2021 | 563 | 0.200 |
Why?
| | Receptors, Antigen, T-Cell | 1 | 2021 | 7 | 0.200 |
Why?
| | Respiratory Function Tests | 1 | 2020 | 16 | 0.200 |
Why?
| | Breast Neoplasms | 1 | 2021 | 38 | 0.200 |
Why?
| | Kidney Transplantation | 1 | 2002 | 114 | 0.200 |
Why?
| | Dose-Response Relationship, Drug | 3 | 2011 | 92 | 0.200 |
Why?
| | Motivation | 1 | 2021 | 64 | 0.200 |
Why?
| | Bacterial Infections | 1 | 2021 | 27 | 0.190 |
Why?
| | Survival Analysis | 2 | 2018 | 46 | 0.190 |
Why?
| | Ligaments | 1 | 2020 | 4 | 0.190 |
Why?
| | Heart Ventricles | 2 | 2018 | 50 | 0.190 |
Why?
| | Constipation | 1 | 2020 | 13 | 0.190 |
Why?
| | Wound Closure Techniques | 1 | 2020 | 1 | 0.190 |
Why?
| | Echocardiography | 1 | 2020 | 78 | 0.190 |
Why?
| | Cross-Over Studies | 1 | 2020 | 32 | 0.190 |
Why?
| | Skin | 1 | 2020 | 13 | 0.190 |
Why?
| | Fibrinolysis | 1 | 2020 | 2 | 0.190 |
Why?
| | Pressure | 3 | 2019 | 11 | 0.190 |
Why?
| | Venous Thromboembolism | 1 | 2020 | 10 | 0.180 |
Why?
| | Thoracentesis | 1 | 2019 | 1 | 0.180 |
Why?
| | Probability | 3 | 2008 | 17 | 0.180 |
Why?
| | Gallbladder | 1 | 2019 | 3 | 0.180 |
Why?
| | Short Bowel Syndrome | 1 | 2019 | 4 | 0.180 |
Why?
| | Congenital Abnormalities | 3 | 2016 | 11 | 0.180 |
Why?
| | Manipulation, Orthopedic | 1 | 2019 | 5 | 0.180 |
Why?
| | Self Report | 1 | 2019 | 43 | 0.180 |
Why?
| | Conversion to Open Surgery | 2 | 2019 | 2 | 0.180 |
Why?
| | Sex Factors | 3 | 2014 | 71 | 0.180 |
Why?
| | Meconium | 2 | 2009 | 3 | 0.170 |
Why?
| | Infusions, Intravenous | 3 | 2021 | 26 | 0.170 |
Why?
| | Pancreatic Pseudocyst | 2 | 2009 | 3 | 0.170 |
Why?
| | Multicenter Studies as Topic | 2 | 2016 | 17 | 0.170 |
Why?
| | Thoracoplasty | 1 | 2018 | 1 | 0.170 |
Why?
| | Pain Perception | 1 | 2018 | 2 | 0.170 |
Why?
| | Anorexia | 1 | 2018 | 2 | 0.170 |
Why?
| | Surgical Instruments | 2 | 2010 | 4 | 0.170 |
Why?
| | Jejunum | 1 | 2018 | 3 | 0.170 |
Why?
| | Urinary Catheters | 1 | 2018 | 2 | 0.170 |
Why?
| | Pancreatic Ducts | 1 | 2018 | 2 | 0.170 |
Why?
| | Syndrome | 2 | 2016 | 33 | 0.170 |
Why?
| | Catheters, Indwelling | 1 | 2018 | 30 | 0.170 |
Why?
| | Analgesics | 1 | 2018 | 5 | 0.170 |
Why?
| | Narcotics | 1 | 2018 | 7 | 0.170 |
Why?
| | Postoperative Hemorrhage | 1 | 2018 | 1 | 0.170 |
Why?
| | Attitude to Health | 1 | 2018 | 35 | 0.170 |
Why?
| | Imaging, Three-Dimensional | 1 | 2018 | 11 | 0.160 |
Why?
| | Prostheses and Implants | 2 | 2011 | 8 | 0.160 |
Why?
| | Pelvic Neoplasms | 1 | 2018 | 3 | 0.160 |
Why?
| | Organs at Risk | 1 | 2018 | 3 | 0.160 |
Why?
| | Checklist | 1 | 2018 | 5 | 0.160 |
Why?
| | Fertility Preservation | 1 | 2018 | 5 | 0.160 |
Why?
| | Reference Standards | 1 | 2018 | 15 | 0.160 |
Why?
| | Analgesics, Non-Narcotic | 1 | 2018 | 7 | 0.160 |
Why?
| | Acetaminophen | 1 | 2018 | 17 | 0.160 |
Why?
| | Cost of Illness | 2 | 2008 | 19 | 0.160 |
Why?
| | Embolization, Therapeutic | 2 | 2017 | 12 | 0.160 |
Why?
| | Magnets | 1 | 2017 | 2 | 0.160 |
Why?
| | Complementary Therapies | 1 | 2017 | 3 | 0.160 |
Why?
| | Counseling | 1 | 2018 | 60 | 0.160 |
Why?
| | Carbon Dioxide | 2 | 2021 | 16 | 0.160 |
Why?
| | Gastroenterology | 1 | 2017 | 10 | 0.150 |
Why?
| | Ileitis | 1 | 2017 | 3 | 0.150 |
Why?
| | Emergency Medical Services | 1 | 2017 | 14 | 0.150 |
Why?
| | Body Weight | 2 | 2019 | 49 | 0.150 |
Why?
| | Clostridium Infections | 1 | 2017 | 7 | 0.150 |
Why?
| | Trachea | 3 | 2017 | 7 | 0.150 |
Why?
| | Hypotension | 1 | 2017 | 4 | 0.150 |
Why?
| | Decision Support Techniques | 2 | 2015 | 9 | 0.150 |
Why?
| | Academic Medical Centers | 1 | 2016 | 9 | 0.150 |
Why?
| | Peritoneal Diseases | 1 | 2016 | 2 | 0.150 |
Why?
| | Program Development | 1 | 2016 | 16 | 0.150 |
Why?
| | Shock, Traumatic | 1 | 2016 | 2 | 0.150 |
Why?
| | Health Status Indicators | 1 | 2016 | 8 | 0.150 |
Why?
| | Vasoconstrictor Agents | 1 | 2016 | 1 | 0.150 |
Why?
| | Infant Formula | 2 | 2013 | 15 | 0.150 |
Why?
| | Weight Loss | 2 | 2008 | 39 | 0.150 |
Why?
| | Cross-Sectional Studies | 2 | 2022 | 317 | 0.150 |
Why?
| | Vocal Cord Paralysis | 2 | 2017 | 2 | 0.140 |
Why?
| | Surgicenters | 1 | 2016 | 2 | 0.140 |
Why?
| | Models, Organizational | 1 | 2016 | 8 | 0.140 |
Why?
| | Global Health | 1 | 2016 | 12 | 0.140 |
Why?
| | False Negative Reactions | 2 | 2017 | 10 | 0.140 |
Why?
| | Surgical Flaps | 2 | 2019 | 7 | 0.140 |
Why?
| | Medical Records | 1 | 2016 | 14 | 0.140 |
Why?
| | Volunteers | 1 | 2016 | 2 | 0.140 |
Why?
| | Comprehension | 1 | 2016 | 2 | 0.140 |
Why?
| | Perception | 1 | 2016 | 9 | 0.140 |
Why?
| | Child Health Services | 1 | 2016 | 24 | 0.140 |
Why?
| | Potassium | 1 | 2016 | 8 | 0.140 |
Why?
| | Resuscitation | 1 | 2016 | 6 | 0.140 |
Why?
| | Heparin | 2 | 2013 | 7 | 0.140 |
Why?
| | Granuloma, Plasma Cell | 1 | 2015 | 2 | 0.140 |
Why?
| | Hospitals | 3 | 2022 | 38 | 0.140 |
Why?
| | Arizona | 3 | 2023 | 9 | 0.140 |
Why?
| | Arkansas | 3 | 2023 | 9 | 0.140 |
Why?
| | Oklahoma | 3 | 2023 | 11 | 0.140 |
Why?
| | Texas | 3 | 2023 | 16 | 0.140 |
Why?
| | Gastric Mucosa | 1 | 2015 | 14 | 0.140 |
Why?
| | Attitude of Health Personnel | 2 | 2021 | 49 | 0.140 |
Why?
| | Upper Gastrointestinal Tract | 1 | 2015 | 4 | 0.140 |
Why?
| | Odds Ratio | 2 | 2012 | 53 | 0.140 |
Why?
| | Constriction, Pathologic | 3 | 2023 | 17 | 0.140 |
Why?
| | Hydromorphone | 1 | 2015 | 1 | 0.130 |
Why?
| | Fentanyl | 1 | 2015 | 1 | 0.130 |
Why?
| | Foreign-Body Reaction | 2 | 2007 | 3 | 0.130 |
Why?
| | Midazolam | 1 | 2015 | 11 | 0.130 |
Why?
| | Anastomotic Leak | 3 | 2023 | 9 | 0.130 |
Why?
| | Sarcoma, Ewing | 1 | 2015 | 7 | 0.130 |
Why?
| | Cathartics | 1 | 2015 | 4 | 0.130 |
Why?
| | Canada | 2 | 2012 | 31 | 0.130 |
Why?
| | Amoxicillin-Potassium Clavulanate Combination | 1 | 2015 | 1 | 0.130 |
Why?
| | Osteosarcoma | 1 | 2015 | 19 | 0.130 |
Why?
| | Remission, Spontaneous | 1 | 2015 | 2 | 0.130 |
Why?
| | Catheters | 1 | 2015 | 3 | 0.130 |
Why?
| | Ankyrins | 1 | 2014 | 1 | 0.130 |
Why?
| | Consensus | 3 | 2020 | 31 | 0.130 |
Why?
| | Gastroplasty | 1 | 2014 | 1 | 0.130 |
Why?
| | Rectal Diseases | 1 | 2014 | 2 | 0.130 |
Why?
| | Acute Chest Syndrome | 1 | 2014 | 2 | 0.130 |
Why?
| | Anemia, Hemolytic, Congenital | 1 | 2014 | 3 | 0.130 |
Why?
| | Benchmarking | 1 | 2014 | 11 | 0.130 |
Why?
| | Health Services Needs and Demand | 1 | 2014 | 17 | 0.130 |
Why?
| | Advisory Committees | 1 | 2014 | 9 | 0.130 |
Why?
| | Apgar Score | 3 | 2019 | 6 | 0.130 |
Why?
| | Quality Indicators, Health Care | 1 | 2014 | 17 | 0.130 |
Why?
| | Electric Impedance | 2 | 2012 | 3 | 0.130 |
Why?
| | Antineoplastic Agents | 2 | 2015 | 57 | 0.130 |
Why?
| | Echocardiography, Transesophageal | 1 | 2014 | 8 | 0.130 |
Why?
| | Diagnostic Techniques, Ophthalmological | 1 | 2014 | 2 | 0.130 |
Why?
| | Pupil | 1 | 2014 | 3 | 0.130 |
Why?
| | Reflex, Pupillary | 1 | 2014 | 3 | 0.130 |
Why?
| | Histological Techniques | 1 | 2014 | 1 | 0.130 |
Why?
| | Heart | 1 | 2014 | 15 | 0.130 |
Why?
| | Rotation | 2 | 2020 | 5 | 0.130 |
Why?
| | Wound Healing | 2 | 2012 | 7 | 0.130 |
Why?
| | Residence Characteristics | 1 | 2014 | 43 | 0.120 |
Why?
| | Burns, Chemical | 1 | 2014 | 1 | 0.120 |
Why?
| | Burns, Electric | 1 | 2014 | 1 | 0.120 |
Why?
| | Foreign-Body Migration | 1 | 2014 | 2 | 0.120 |
Why?
| | Extravasation of Diagnostic and Therapeutic Materials | 1 | 2014 | 4 | 0.120 |
Why?
| | Seizures | 1 | 2014 | 23 | 0.120 |
Why?
| | Diagnostic Techniques, Digestive System | 2 | 2012 | 5 | 0.120 |
Why?
| | Blood Loss, Surgical | 2 | 2012 | 5 | 0.120 |
Why?
| | Solutions | 1 | 2013 | 4 | 0.120 |
Why?
| | Patients | 1 | 2013 | 3 | 0.120 |
Why?
| | Hematuria | 1 | 2013 | 7 | 0.120 |
Why?
| | Urinalysis | 1 | 2013 | 5 | 0.120 |
Why?
| | Insurance, Health, Reimbursement | 2 | 2020 | 4 | 0.120 |
Why?
| | Respiratory Sounds | 1 | 2013 | 6 | 0.120 |
Why?
| | Tertiary Care Centers | 1 | 2013 | 10 | 0.120 |
Why?
| | Nephrectomy | 1 | 2013 | 15 | 0.120 |
Why?
| | Cough | 1 | 2013 | 7 | 0.120 |
Why?
| | Appointments and Schedules | 1 | 2013 | 13 | 0.120 |
Why?
| | Time | 1 | 2013 | 6 | 0.120 |
Why?
| | Oxycodone | 1 | 2013 | 4 | 0.120 |
Why?
| | Symptom Assessment | 1 | 2013 | 12 | 0.120 |
Why?
| | Quality Assurance, Health Care | 1 | 2013 | 6 | 0.120 |
Why?
| | Interviews as Topic | 1 | 2013 | 36 | 0.120 |
Why?
| | Remission Induction | 1 | 2013 | 25 | 0.120 |
Why?
| | Respiratory Tract Infections | 1 | 2014 | 75 | 0.120 |
Why?
| | Fraud | 1 | 2013 | 2 | 0.120 |
Why?
| | Risk | 1 | 2013 | 40 | 0.120 |
Why?
| | Publishing | 1 | 2013 | 6 | 0.120 |
Why?
| | Authorship | 1 | 2013 | 3 | 0.120 |
Why?
| | Walking | 1 | 2013 | 35 | 0.120 |
Why?
| | Food | 1 | 2013 | 18 | 0.120 |
Why?
| | Venous Cutdown | 1 | 2013 | 1 | 0.120 |
Why?
| | Jugular Veins | 1 | 2013 | 3 | 0.120 |
Why?
| | Fellowships and Scholarships | 1 | 2013 | 16 | 0.120 |
Why?
| | Diet | 1 | 2013 | 54 | 0.120 |
Why?
| | Enoxaparin | 1 | 2013 | 3 | 0.110 |
Why?
| | Ileus | 2 | 2009 | 3 | 0.110 |
Why?
| | Ethics, Research | 1 | 2012 | 1 | 0.110 |
Why?
| | Organ Specificity | 2 | 2011 | 22 | 0.110 |
Why?
| | Muscle, Smooth | 1 | 2012 | 2 | 0.110 |
Why?
| | Body Size | 1 | 2012 | 7 | 0.110 |
Why?
| | Organ Size | 1 | 2012 | 13 | 0.110 |
Why?
| | Hospitals, Teaching | 1 | 2012 | 4 | 0.110 |
Why?
| | Polymyxins | 1 | 2012 | 3 | 0.110 |
Why?
| | Wound Infection | 1 | 2012 | 4 | 0.110 |
Why?
| | Administration, Topical | 1 | 2012 | 6 | 0.110 |
Why?
| | Inguinal Canal | 2 | 2015 | 3 | 0.110 |
Why?
| | Ointments | 1 | 2012 | 6 | 0.110 |
Why?
| | Education, Medical | 1 | 2012 | 3 | 0.110 |
Why?
| | Drug Costs | 1 | 2012 | 4 | 0.110 |
Why?
| | Hypoxia, Brain | 1 | 2012 | 1 | 0.110 |
Why?
| | Sex Distribution | 2 | 2012 | 17 | 0.110 |
Why?
| | Ultrasonography, Prenatal | 1 | 2012 | 8 | 0.110 |
Why?
| | Polytetrafluoroethylene | 1 | 2012 | 1 | 0.110 |
Why?
| | Uncertainty | 1 | 2012 | 10 | 0.110 |
Why?
| | Diarrhea | 1 | 2012 | 18 | 0.110 |
Why?
| | Voice Quality | 1 | 2011 | 1 | 0.110 |
Why?
| | Thoracic Vertebrae | 1 | 2011 | 4 | 0.110 |
Why?
| | Sternum | 1 | 2011 | 6 | 0.110 |
Why?
| | Polymerase Chain Reaction | 1 | 2012 | 82 | 0.110 |
Why?
| | Disease Susceptibility | 1 | 2011 | 10 | 0.110 |
Why?
| | Methylprednisolone | 1 | 2011 | 3 | 0.100 |
Why?
| | Neuroprotective Agents | 1 | 2011 | 3 | 0.100 |
Why?
| | Spinal Cord Injuries | 1 | 2011 | 4 | 0.100 |
Why?
| | Biomarkers | 1 | 2012 | 120 | 0.100 |
Why?
| | Cerebral Palsy | 1 | 2012 | 16 | 0.100 |
Why?
| | Blood Gas Analysis | 1 | 2011 | 6 | 0.100 |
Why?
| | Blister | 1 | 2011 | 2 | 0.100 |
Why?
| | Oximetry | 1 | 2011 | 9 | 0.100 |
Why?
| | Mediastinal Neoplasms | 1 | 2011 | 5 | 0.100 |
Why?
| | Catheter-Related Infections | 1 | 2011 | 19 | 0.100 |
Why?
| | Personnel Selection | 1 | 2011 | 3 | 0.100 |
Why?
| | Reference Values | 1 | 2011 | 40 | 0.100 |
Why?
| | Colonic Pouches | 1 | 2011 | 1 | 0.100 |
Why?
| | Hand Injuries | 1 | 2011 | 3 | 0.100 |
Why?
| | Early Diagnosis | 1 | 2011 | 33 | 0.100 |
Why?
| | Dermatofibrosarcoma | 1 | 2011 | 1 | 0.100 |
Why?
| | Bacteremia | 1 | 2011 | 25 | 0.100 |
Why?
| | Fibrin Tissue Adhesive | 2 | 2008 | 2 | 0.100 |
Why?
| | Bronchial Fistula | 2 | 2008 | 3 | 0.100 |
Why?
| | Early Ambulation | 1 | 2011 | 3 | 0.100 |
Why?
| | Skin Neoplasms | 1 | 2011 | 8 | 0.100 |
Why?
| | Bibliometrics | 1 | 2010 | 1 | 0.100 |
Why?
| | Journal Impact Factor | 1 | 2010 | 1 | 0.100 |
Why?
| | Cross-Cultural Comparison | 1 | 2010 | 3 | 0.100 |
Why?
| | Research Support as Topic | 1 | 2010 | 4 | 0.100 |
Why?
| | Research | 1 | 2010 | 11 | 0.100 |
Why?
| | Neoadjuvant Therapy | 1 | 2010 | 6 | 0.100 |
Why?
| | Periodicals as Topic | 1 | 2010 | 4 | 0.100 |
Why?
| | Patient Admission | 1 | 2010 | 9 | 0.100 |
Why?
| | Amoxicillin | 1 | 2010 | 4 | 0.100 |
Why?
| | History, 20th Century | 1 | 2010 | 5 | 0.100 |
Why?
| | Prosthesis Design | 1 | 2010 | 9 | 0.100 |
Why?
| | History, 21st Century | 1 | 2010 | 5 | 0.100 |
Why?
| | Abdominal Neoplasms | 1 | 2010 | 5 | 0.090 |
Why?
| | Coated Materials, Biocompatible | 2 | 2011 | 2 | 0.090 |
Why?
| | Gynecomastia | 1 | 2010 | 2 | 0.090 |
Why?
| | Intestinal Diseases | 1 | 2010 | 4 | 0.090 |
Why?
| | Mastectomy, Subcutaneous | 1 | 2010 | 3 | 0.090 |
Why?
| | Dyspnea | 2 | 2020 | 4 | 0.090 |
Why?
| | Diphenhydramine | 1 | 2010 | 2 | 0.090 |
Why?
| | Mammaplasty | 1 | 2010 | 4 | 0.090 |
Why?
| | Diagnostic Errors | 1 | 2010 | 7 | 0.090 |
Why?
| | Intestines | 1 | 2010 | 26 | 0.090 |
Why?
| | Attitude | 1 | 2010 | 12 | 0.090 |
Why?
| | Leukemic Infiltration | 1 | 2009 | 3 | 0.090 |
Why?
| | Meconium Aspiration Syndrome | 1 | 2009 | 4 | 0.090 |
Why?
| | Hydrocephalus | 1 | 2009 | 8 | 0.090 |
Why?
| | Infarction | 1 | 2009 | 2 | 0.090 |
Why?
| | Cystic Fibrosis | 1 | 2009 | 18 | 0.090 |
Why?
| | Professional Practice | 1 | 2009 | 4 | 0.090 |
Why?
| | Respiratory Distress Syndrome, Newborn | 2 | 2021 | 7 | 0.090 |
Why?
| | Duodenostomy | 1 | 2009 | 1 | 0.090 |
Why?
| | Jejunostomy | 1 | 2009 | 2 | 0.090 |
Why?
| | Atrophy | 2 | 2022 | 6 | 0.090 |
Why?
| | Adrenocortical Adenoma | 1 | 2009 | 2 | 0.090 |
Why?
| | Injections, Intralesional | 1 | 2009 | 1 | 0.090 |
Why?
| | Adrenal Cortex Neoplasms | 1 | 2009 | 3 | 0.090 |
Why?
| | Hypertension, Renal | 1 | 2009 | 4 | 0.090 |
Why?
| | Peritoneal Cavity | 1 | 2008 | 3 | 0.090 |
Why?
| | Accidents | 1 | 2008 | 3 | 0.090 |
Why?
| | Biliary Tract Diseases | 1 | 2008 | 4 | 0.090 |
Why?
| | Fecal Impaction | 1 | 2008 | 3 | 0.090 |
Why?
| | Perfusion | 3 | 2003 | 8 | 0.090 |
Why?
| | Dehydration | 1 | 2008 | 2 | 0.090 |
Why?
| | Infant Food | 1 | 2008 | 6 | 0.090 |
Why?
| | Surgical Stapling | 1 | 2008 | 1 | 0.090 |
Why?
| | Glucocorticoids | 1 | 2009 | 29 | 0.080 |
Why?
| | Failure to Thrive | 1 | 2008 | 7 | 0.080 |
Why?
| | Goals | 1 | 2008 | 8 | 0.080 |
Why?
| | Precancerous Conditions | 1 | 2008 | 6 | 0.080 |
Why?
| | Peutz-Jeghers Syndrome | 1 | 2008 | 5 | 0.080 |
Why?
| | Midwestern United States | 2 | 2019 | 39 | 0.080 |
Why?
| | Duodenoscopy | 1 | 2008 | 3 | 0.080 |
Why?
| | Work Schedule Tolerance | 1 | 2008 | 5 | 0.080 |
Why?
| | Quality of Health Care | 1 | 2008 | 13 | 0.080 |
Why?
| | Personnel Staffing and Scheduling | 1 | 2008 | 14 | 0.080 |
Why?
| | Multivariate Analysis | 1 | 2008 | 74 | 0.080 |
Why?
| | Cholangiography | 1 | 2008 | 2 | 0.080 |
Why?
| | Cystic Duct | 1 | 2008 | 2 | 0.080 |
Why?
| | Choledocholithiasis | 1 | 2008 | 2 | 0.080 |
Why?
| | Observation | 1 | 2008 | 2 | 0.080 |
Why?
| | Disease Progression | 1 | 2008 | 104 | 0.080 |
Why?
| | Surgical Equipment | 1 | 2007 | 1 | 0.080 |
Why?
| | Down Syndrome | 1 | 2008 | 39 | 0.080 |
Why?
| | Wandering Spleen | 1 | 2007 | 1 | 0.080 |
Why?
| | Cysts | 1 | 2007 | 4 | 0.080 |
Why?
| | Silk | 1 | 2007 | 1 | 0.080 |
Why?
| | Spinal Diseases | 1 | 2007 | 2 | 0.080 |
Why?
| | Urinary Tract | 1 | 2007 | 6 | 0.080 |
Why?
| | Gram-Positive Bacterial Infections | 1 | 2007 | 7 | 0.080 |
Why?
| | Mullerian Ducts | 1 | 2006 | 3 | 0.070 |
Why?
| | Uterus | 1 | 2006 | 8 | 0.070 |
Why?
| | Swine | 2 | 2003 | 5 | 0.070 |
Why?
| | In Vitro Techniques | 2 | 2003 | 20 | 0.070 |
Why?
| | Relative Value Scales | 1 | 2006 | 2 | 0.070 |
Why?
| | Respiration, Artificial | 2 | 2019 | 16 | 0.070 |
Why?
| | Urachus | 1 | 2005 | 3 | 0.070 |
Why?
| | Urinary Bladder | 1 | 2005 | 5 | 0.070 |
Why?
| | Urethra | 1 | 2005 | 5 | 0.070 |
Why?
| | Cesarean Section | 1 | 2005 | 3 | 0.070 |
Why?
| | Bandages, Hydrocolloid | 1 | 2005 | 1 | 0.070 |
Why?
| | Ischemia | 2 | 2002 | 7 | 0.070 |
Why?
| | Hypospadias | 1 | 2005 | 3 | 0.070 |
Why?
| | Bilirubin | 2 | 2015 | 25 | 0.070 |
Why?
| | Hemoglobins | 2 | 2015 | 26 | 0.070 |
Why?
| | Obesity, Morbid | 1 | 2005 | 9 | 0.070 |
Why?
| | Laryngoscopy | 2 | 2017 | 2 | 0.070 |
Why?
| | Dilatation, Pathologic | 1 | 2004 | 6 | 0.060 |
Why?
| | Mitomycin | 1 | 2003 | 1 | 0.060 |
Why?
| | Cisplatin | 1 | 2003 | 8 | 0.060 |
Why?
| | Doxorubicin | 1 | 2003 | 17 | 0.060 |
Why?
| | Allopurinol | 1 | 2003 | 1 | 0.060 |
Why?
| | Raffinose | 1 | 2003 | 1 | 0.060 |
Why?
| | Organ Preservation Solutions | 1 | 2003 | 1 | 0.060 |
Why?
| | Tissue and Organ Harvesting | 1 | 2003 | 2 | 0.060 |
Why?
| | Models, Animal | 1 | 2003 | 6 | 0.060 |
Why?
| | Osteogenesis | 1 | 2003 | 6 | 0.060 |
Why?
| | Glutathione | 1 | 2003 | 11 | 0.060 |
Why?
| | Urea | 1 | 2003 | 11 | 0.060 |
Why?
| | Adenosine | 1 | 2003 | 8 | 0.060 |
Why?
| | Homeostasis | 1 | 2003 | 7 | 0.060 |
Why?
| | Palliative Care | 2 | 2014 | 17 | 0.060 |
Why?
| | Insulin | 1 | 2003 | 46 | 0.060 |
Why?
| | Frozen Sections | 1 | 2022 | 1 | 0.060 |
Why?
| | Interrupted Time Series Analysis | 1 | 2022 | 1 | 0.060 |
Why?
| | Bile | 1 | 2002 | 2 | 0.060 |
Why?
| | Patient Transfer | 1 | 2022 | 8 | 0.060 |
Why?
| | Morphine | 1 | 2022 | 11 | 0.050 |
Why?
| | Fatty Liver | 1 | 2002 | 4 | 0.050 |
Why?
| | Healthcare Disparities | 1 | 2022 | 20 | 0.050 |
Why?
| | Tissue Donors | 1 | 2002 | 28 | 0.050 |
Why?
| | Cryopreservation | 1 | 2002 | 4 | 0.050 |
Why?
| | Intensive Care Units | 1 | 2022 | 17 | 0.050 |
Why?
| | Photography | 1 | 2021 | 4 | 0.050 |
Why?
| | Infant, Extremely Low Birth Weight | 1 | 2021 | 9 | 0.050 |
Why?
| | Outpatients | 1 | 2021 | 28 | 0.050 |
Why?
| | Ultrasonography, Mammary | 1 | 2021 | 1 | 0.050 |
Why?
| | Biopsy, Large-Core Needle | 1 | 2021 | 2 | 0.050 |
Why?
| | Breast | 1 | 2021 | 4 | 0.050 |
Why?
| | Ribonuclease III | 1 | 2021 | 2 | 0.050 |
Why?
| | DEAD-box RNA Helicases | 1 | 2021 | 3 | 0.050 |
Why?
| | Neoplasm Metastasis | 1 | 2021 | 15 | 0.050 |
Why?
| | Insurance Benefits | 1 | 2020 | 1 | 0.050 |
Why?
| | BK Virus | 1 | 2021 | 3 | 0.050 |
Why?
| | Infusion Pumps | 1 | 2021 | 5 | 0.050 |
Why?
| | Mucormycosis | 1 | 2021 | 4 | 0.050 |
Why?
| | Hospitals, University | 1 | 2020 | 4 | 0.050 |
Why?
| | Delphi Technique | 1 | 2020 | 10 | 0.050 |
Why?
| | Cell Line, Tumor | 1 | 2021 | 87 | 0.050 |
Why?
| | Medicaid | 1 | 2020 | 37 | 0.050 |
Why?
| | Nausea | 1 | 2020 | 15 | 0.050 |
Why?
| | Blood Component Transfusion | 1 | 2020 | 1 | 0.050 |
Why?
| | Plasma | 1 | 2020 | 7 | 0.050 |
Why?
| | Mutation | 1 | 2021 | 194 | 0.050 |
Why?
| | Parenteral Nutrition | 1 | 2019 | 7 | 0.050 |
Why?
| | Infant, Low Birth Weight | 1 | 2019 | 13 | 0.040 |
Why?
| | Age of Onset | 2 | 2013 | 27 | 0.040 |
Why?
| | Shock | 1 | 2019 | 4 | 0.040 |
Why?
| | Prolapse | 1 | 2018 | 3 | 0.040 |
Why?
| | Aorta, Thoracic | 1 | 2018 | 8 | 0.040 |
Why?
| | Preoperative Period | 1 | 2018 | 5 | 0.040 |
Why?
| | Primary Ovarian Insufficiency | 1 | 2018 | 3 | 0.040 |
Why?
| | Puberty | 1 | 2018 | 5 | 0.040 |
Why?
| | Program Evaluation | 1 | 2018 | 52 | 0.040 |
Why?
| | Urinary Tract Infections | 1 | 2018 | 17 | 0.040 |
Why?
| | Biliary Atresia | 1 | 2017 | 2 | 0.040 |
Why?
| | Angiography | 1 | 2017 | 8 | 0.040 |
Why?
| | Infant Care | 1 | 2017 | 4 | 0.040 |
Why?
| | Recurrent Laryngeal Nerve Injuries | 1 | 2017 | 1 | 0.040 |
Why?
| | Tennessee | 1 | 2017 | 1 | 0.040 |
Why?
| | Tracheostomy | 1 | 2017 | 11 | 0.040 |
Why?
| | Parenteral Nutrition, Total | 1 | 2017 | 7 | 0.040 |
Why?
| | Intensive Care Units, Neonatal | 1 | 2017 | 31 | 0.040 |
Why?
| | Vancomycin | 1 | 2017 | 17 | 0.040 |
Why?
| | Exercise | 1 | 2018 | 125 | 0.040 |
Why?
| | Peritonitis | 1 | 2017 | 52 | 0.040 |
Why?
| | Asymptomatic Diseases | 1 | 2016 | 5 | 0.040 |
Why?
| | Cooperative Behavior | 1 | 2016 | 26 | 0.040 |
Why?
| | Rare Diseases | 1 | 2017 | 37 | 0.040 |
Why?
| | Ligation | 1 | 2015 | 3 | 0.030 |
Why?
| | Chemotherapy, Adjuvant | 1 | 2015 | 4 | 0.030 |
Why?
| | Reticulocyte Count | 1 | 2015 | 1 | 0.030 |
Why?
| | Reticulocytes | 1 | 2014 | 1 | 0.030 |
Why?
| | Intra-Abdominal Hypertension | 1 | 2014 | 2 | 0.030 |
Why?
| | Thinness | 1 | 2014 | 7 | 0.030 |
Why?
| | Analysis of Variance | 1 | 2014 | 24 | 0.030 |
Why?
| | Regional Medical Programs | 1 | 2014 | 1 | 0.030 |
Why?
| | Hospitals, High-Volume | 1 | 2014 | 2 | 0.030 |
Why?
| | Anesthesia | 1 | 2014 | 3 | 0.030 |
Why?
| | Appendiceal Neoplasms | 1 | 2014 | 2 | 0.030 |
Why?
| | Carcinoid Tumor | 1 | 2014 | 2 | 0.030 |
Why?
| | Cecal Diseases | 1 | 2014 | 2 | 0.030 |
Why?
| | Intestinal Neoplasms | 1 | 2014 | 2 | 0.030 |
Why?
| | Enterobiasis | 1 | 2014 | 2 | 0.030 |
Why?
| | Kansas | 1 | 2014 | 49 | 0.030 |
Why?
| | Granuloma | 1 | 2014 | 4 | 0.030 |
Why?
| | Incidental Findings | 1 | 2014 | 8 | 0.030 |
Why?
| | Respiratory Tract Diseases | 1 | 2014 | 8 | 0.030 |
Why?
| | Electronic Health Records | 1 | 2014 | 61 | 0.030 |
Why?
| | Multiple Birth Offspring | 1 | 2013 | 2 | 0.030 |
Why?
| | Competitive Behavior | 1 | 2013 | 2 | 0.030 |
Why?
| | Job Application | 1 | 2013 | 2 | 0.030 |
Why?
| | Feces | 1 | 2013 | 37 | 0.030 |
Why?
| | Confidence Intervals | 1 | 2012 | 12 | 0.030 |
Why?
| | Pleural Cavity | 1 | 2012 | 1 | 0.030 |
Why?
| | Deoxyribonucleases | 1 | 2012 | 2 | 0.030 |
Why?
| | Expectorants | 1 | 2012 | 2 | 0.030 |
Why?
| | Enterostomy | 1 | 2012 | 2 | 0.030 |
Why?
| | Probiotics | 1 | 2012 | 7 | 0.030 |
Why?
| | Pneumonia, Bacterial | 1 | 2012 | 4 | 0.030 |
Why?
| | Temperature | 2 | 2002 | 10 | 0.030 |
Why?
| | Tracheotomy | 1 | 2011 | 1 | 0.030 |
Why?
| | Disinfection | 1 | 2011 | 1 | 0.030 |
Why?
| | Chlorhexidine | 1 | 2011 | 2 | 0.030 |
Why?
| | Bandages | 1 | 2011 | 3 | 0.030 |
Why?
| | Povidone-Iodine | 1 | 2011 | 3 | 0.030 |
Why?
| | Meta-Analysis as Topic | 1 | 2011 | 13 | 0.030 |
Why?
| | Ethanol | 1 | 2011 | 7 | 0.030 |
Why?
| | Anti-Infective Agents, Local | 1 | 2011 | 7 | 0.030 |
Why?
| | Mediastinum | 1 | 2011 | 5 | 0.030 |
Why?
| | Lymphoma | 1 | 2011 | 9 | 0.030 |
Why?
| | Leukemia | 1 | 2011 | 17 | 0.020 |
Why?
| | Statistics as Topic | 1 | 2011 | 18 | 0.020 |
Why?
| | Cardiac Surgical Procedures | 1 | 2011 | 30 | 0.020 |
Why?
| | Foundations | 1 | 2010 | 1 | 0.020 |
Why?
| | United States Public Health Service | 1 | 2010 | 1 | 0.020 |
Why?
| | Committee Membership | 1 | 2010 | 1 | 0.020 |
Why?
| | National Institutes of Health (U.S.) | 1 | 2010 | 4 | 0.020 |
Why?
| | Electronic Mail | 1 | 2010 | 2 | 0.020 |
Why?
| | Financial Support | 1 | 2010 | 2 | 0.020 |
Why?
| | Data Collection | 1 | 2010 | 32 | 0.020 |
Why?
| | Gastrointestinal Motility | 1 | 2010 | 5 | 0.020 |
Why?
| | Nipples | 1 | 2010 | 3 | 0.020 |
Why?
| | Diatrizoate Meglumine | 1 | 2009 | 1 | 0.020 |
Why?
| | Hypertrophy | 1 | 2009 | 4 | 0.020 |
Why?
| | Omentum | 1 | 2009 | 3 | 0.020 |
Why?
| | Pneumoperitoneum | 1 | 2009 | 2 | 0.020 |
Why?
| | Hospital Mortality | 1 | 2009 | 21 | 0.020 |
Why?
| | Hamartoma | 1 | 2008 | 3 | 0.020 |
Why?
| | Cell Transformation, Neoplastic | 1 | 2008 | 14 | 0.020 |
Why?
| | Pregnancy in Diabetics | 1 | 2008 | 2 | 0.020 |
Why?
| | Esophageal Fistula | 1 | 2008 | 2 | 0.020 |
Why?
| | Thoracic Neoplasms | 1 | 2008 | 2 | 0.020 |
Why?
| | Respiratory Tract Fistula | 1 | 2008 | 2 | 0.020 |
Why?
| | Hemothorax | 1 | 2008 | 3 | 0.020 |
Why?
| | Scoliosis | 1 | 2008 | 5 | 0.020 |
Why?
| | Aspergillosis | 1 | 2007 | 1 | 0.020 |
Why?
| | Lung Diseases, Fungal | 1 | 2007 | 1 | 0.020 |
Why?
| | Operating Rooms | 1 | 2007 | 4 | 0.020 |
Why?
| | Pharmacy Service, Hospital | 1 | 2007 | 8 | 0.020 |
Why?
| | Emergencies | 1 | 2007 | 11 | 0.020 |
Why?
| | Chi-Square Distribution | 1 | 2007 | 34 | 0.020 |
Why?
| | Peptostreptococcus | 1 | 2007 | 1 | 0.020 |
Why?
| | Cystectomy | 1 | 2007 | 1 | 0.020 |
Why?
| | Pelvis | 1 | 2007 | 3 | 0.020 |
Why?
| | Genetic Predisposition to Disease | 1 | 2008 | 215 | 0.020 |
Why?
| | Disorders of Sex Development | 1 | 2006 | 9 | 0.020 |
Why?
| | Neoplasms | 1 | 2008 | 119 | 0.020 |
Why?
| | Urination | 1 | 2005 | 2 | 0.020 |
Why?
| | Diagnostic Tests, Routine | 1 | 2005 | 17 | 0.020 |
Why?
| | Health Care Costs | 1 | 2005 | 29 | 0.020 |
Why?
| | Costs and Cost Analysis | 1 | 2005 | 6 | 0.020 |
Why?
| | Causality | 1 | 2003 | 10 | 0.010 |
Why?
| | Hemolysis | 1 | 2002 | 3 | 0.010 |
Why?
| | Kinetics | 1 | 2002 | 30 | 0.010 |
Why?
| | Hypothermia, Induced | 1 | 2001 | 1 | 0.010 |
Why?
| | Reperfusion | 1 | 2001 | 1 | 0.010 |
Why?
|
|
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|